Hayes GM - Search Results

1

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.

Long BR, Veron P, Kuranda K, Hardet R, Mitchell N, Hayes GM, Wong WY, Lau K, Li M, Hock MB, Zoog SJ, Vettermann C, Mingozzi F, Schweighardt B. Long BR, et al. Among authors: hayes gm. Mol Ther. 2021 Feb 3;29(2):597-610. doi: 10.1016/j.ymthe.2020.12.008. Epub 2020 Dec 10. Mol Ther. 2021. PMID: 33309883 Free PMC article.

2

The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy.

Long BR, Sandza K, Holcomb J, Crockett L, Hayes GM, Arens J, Fonck C, Tsuruda LS, Schweighardt B, O'Neill CA, Zoog S, Vettermann C. Long BR, et al. Among authors: hayes gm. Mol Ther Methods Clin Dev. 2019 Apr 11;13:440-452. doi: 10.1016/j.omtm.2019.03.006. eCollection 2019 Jun 14. Mol Ther Methods Clin Dev. 2019. PMID: 31193016 Free PMC article.

3

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.

Klamroth R, Hayes G, Andreeva T, Gregg K, Suzuki T, Mitha IH, Hardesty B, Shima M, Pollock T, Slev P, Oldenburg J, Ozelo MC, Stieltjes N, Castet SM, Mahlangu J, Peyvandi F, Kazmi R, Schved JF, Leavitt AD, Callaghan M, Pan-Petesch B, Quon DV, Andrews J, Trinh A, Li M, Wong WY. Klamroth R, et al. Hum Gene Ther. 2022 Apr;33(7-8):432-441. doi: 10.1089/hum.2021.287. Epub 2022 Mar 16. Hum Gene Ther. 2022. PMID: 35156839 Free PMC article.

4

Adenovirus-associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus-associated virus vector-serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A.

Stanford S, Pink R, Creagh D, Clark A, Lowe G, Curry N, Pasi J, Perry D, Fong S, Hayes G, Chandrakumaran K, Rangarajan S. Stanford S, et al. Res Pract Thromb Haemost. 2019 Jan 25;3(2):261-267. doi: 10.1002/rth2.12177. eCollection 2019 Apr. Res Pract Thromb Haemost. 2019. PMID: 31011710 Free PMC article.

5

Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.

Bu W, Hayes GM, Liu H, Gemmell L, Schmeling DO, Radecki P, Aguilar F, Burbelo PD, Woo J, Balfour HH Jr, Cohen JI. Bu W, et al. Among authors: hayes gm. Clin Vaccine Immunol. 2016 Apr 4;23(4):363-9. doi: 10.1128/CVI.00674-15. Print 2016 Apr. Clin Vaccine Immunol. 2016. PMID: 26888186 Free PMC article.

6

Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo.

Servat E, Ro BW, Cayatte C, Gemmell L, Barton C, Rao E, Lin R, Zuo F, Woo JC, Hayes GM. Servat E, et al. Among authors: hayes gm. Vaccine. 2015 Nov 27;33(48):6771-7. doi: 10.1016/j.vaccine.2015.10.024. Epub 2015 Oct 17. Vaccine. 2015. PMID: 26485517

7

Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection.

Geris JM, Stancari AL, Meirhaeghe MR, Gautam S, Cayatte C, Schmeling DO, Okour MF, Brundage RC, Hayes GM, Balfour HH Jr. Geris JM, et al. Among authors: hayes gm. J Clin Virol. 2022 Oct;155:105267. doi: 10.1016/j.jcv.2022.105267. Epub 2022 Aug 17. J Clin Virol. 2022. PMID: 36007460

8

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine.

Liu H, Gemmell L, Lin R, Zuo F, Balfour HH Jr, Woo JC, Hayes GM. Liu H, et al. Among authors: hayes gm. Mediterr J Hematol Infect Dis. 2020 Mar 1;12(1):e2020016. doi: 10.4084/MJHID.2020.016. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32180911 Free PMC article.

9

Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.

Cayatte C, Schneider-Ohrum K, Wang Z, Irrinki A, Nguyen N, Lu J, Nelson C, Servat E, Gemmell L, Citkowicz A, Liu Y, Hayes G, Woo J, Van Nest G, Jin H, Duke G, McCormick AL. Cayatte C, et al. J Virol. 2013 Oct;87(20):11107-20. doi: 10.1128/JVI.01554-13. Epub 2013 Aug 7. J Virol. 2013. PMID: 23926341 Free PMC article.

10

Incidence of residual biologic debris and contamination of reused bipolar vessel sealing devices after ethylene oxide sterilization following splenectomy.

Folk CA, Buote NJ, Socha DE, Hayes GM. Folk CA, et al. Among authors: hayes gm. Vet Surg. 2024 Aug 16. doi: 10.1111/vsu.14153. Online ahead of print. Vet Surg. 2024. PMID: 39149916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters